Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diagnosis | 4 | 2022 | 156 | 0.960 |
Why?
|
Hospital Administration | 3 | 2021 | 353 | 0.930 |
Why?
|
Employee Incentive Plans | 2 | 2013 | 15 | 0.900 |
Why?
|
Public Health Practice | 4 | 2022 | 221 | 0.890 |
Why?
|
Influenza A Virus, H1N1 Subtype | 4 | 2014 | 450 | 0.880 |
Why?
|
Delivery of Health Care | 15 | 2022 | 5367 | 0.870 |
Why?
|
Health Policy | 12 | 2022 | 2699 | 0.860 |
Why?
|
Government Regulation | 4 | 2022 | 525 | 0.860 |
Why?
|
Preventive Medicine | 3 | 2013 | 245 | 0.850 |
Why?
|
Science | 2 | 2020 | 239 | 0.800 |
Why?
|
Policy Making | 5 | 2017 | 545 | 0.760 |
Why?
|
Primary Prevention | 3 | 2013 | 1189 | 0.760 |
Why?
|
Public Health | 12 | 2012 | 2693 | 0.740 |
Why?
|
Health Communication | 1 | 2024 | 216 | 0.720 |
Why?
|
Internationality | 4 | 2017 | 1007 | 0.710 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2022 | 219 | 0.710 |
Why?
|
Disease Outbreaks | 6 | 2009 | 1764 | 0.700 |
Why?
|
Research Support as Topic | 2 | 2015 | 699 | 0.680 |
Why?
|
United States Environmental Protection Agency | 1 | 2020 | 139 | 0.660 |
Why?
|
Health Personnel | 5 | 2024 | 3384 | 0.660 |
Why?
|
Vaccines | 2 | 2024 | 845 | 0.660 |
Why?
|
Influenza, Human | 5 | 2014 | 1540 | 0.650 |
Why?
|
Research | 5 | 2020 | 1984 | 0.650 |
Why?
|
Communicable Disease Control | 5 | 2022 | 857 | 0.630 |
Why?
|
Medicine | 3 | 2024 | 946 | 0.620 |
Why?
|
Public Health Administration | 2 | 2022 | 242 | 0.620 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2015 | 794 | 0.620 |
Why?
|
Health Promotion | 7 | 2013 | 2215 | 0.610 |
Why?
|
Pandemics | 5 | 2024 | 8753 | 0.560 |
Why?
|
Quality of Health Care | 7 | 2021 | 4340 | 0.550 |
Why?
|
Infection Control | 2 | 2021 | 985 | 0.540 |
Why?
|
Conflict of Interest | 3 | 2017 | 556 | 0.510 |
Why?
|
Systems Analysis | 1 | 2016 | 168 | 0.510 |
Why?
|
Biomedical Research | 6 | 2022 | 3463 | 0.510 |
Why?
|
Rehabilitation | 2 | 2007 | 131 | 0.510 |
Why?
|
Public Policy | 3 | 2017 | 560 | 0.490 |
Why?
|
Capital Financing | 1 | 2015 | 58 | 0.480 |
Why?
|
United States | 67 | 2022 | 73121 | 0.470 |
Why?
|
Virus Diseases | 2 | 2015 | 723 | 0.460 |
Why?
|
Budgets | 2 | 2013 | 232 | 0.460 |
Why?
|
Federal Government | 3 | 2015 | 266 | 0.450 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3116 | 0.440 |
Why?
|
Spirurida Infections | 1 | 2013 | 3 | 0.440 |
Why?
|
Life Expectancy | 5 | 2014 | 1249 | 0.420 |
Why?
|
Social Values | 2 | 2013 | 225 | 0.410 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3240 | 0.400 |
Why?
|
Poliomyelitis | 1 | 2013 | 92 | 0.400 |
Why?
|
Government | 1 | 2012 | 162 | 0.390 |
Why?
|
Health Services Research | 4 | 2015 | 1815 | 0.380 |
Why?
|
Surgical Procedures, Operative | 3 | 2021 | 1937 | 0.380 |
Why?
|
Viruses | 1 | 2015 | 373 | 0.370 |
Why?
|
Influenza Vaccines | 2 | 2009 | 781 | 0.370 |
Why?
|
Drug Approval | 2 | 2008 | 817 | 0.350 |
Why?
|
Health Care Reform | 3 | 2010 | 1256 | 0.330 |
Why?
|
Acquired Immunodeficiency Syndrome | 9 | 1991 | 2203 | 0.320 |
Why?
|
Pertussis Vaccine | 4 | 1993 | 39 | 0.320 |
Why?
|
Medication Errors | 2 | 2006 | 783 | 0.320 |
Why?
|
Mortality | 1 | 2020 | 2917 | 0.320 |
Why?
|
United States Food and Drug Administration | 3 | 2007 | 1669 | 0.310 |
Why?
|
Rubella Vaccine | 3 | 1992 | 23 | 0.310 |
Why?
|
Psychiatry | 2 | 2019 | 1714 | 0.300 |
Why?
|
Informed Consent | 2 | 2008 | 1012 | 0.290 |
Why?
|
Humans | 125 | 2024 | 768451 | 0.290 |
Why?
|
Polybrominated Biphenyls | 1 | 2007 | 25 | 0.290 |
Why?
|
Mercury Poisoning | 1 | 2007 | 32 | 0.290 |
Why?
|
Efficiency, Organizational | 1 | 2012 | 699 | 0.280 |
Why?
|
Education, Medical | 7 | 2011 | 1742 | 0.280 |
Why?
|
Anti-Retroviral Agents | 1 | 2017 | 1794 | 0.280 |
Why?
|
Feeding Behavior | 4 | 2007 | 3202 | 0.280 |
Why?
|
Tuberculosis | 6 | 2001 | 2030 | 0.280 |
Why?
|
Obesity | 5 | 2013 | 13065 | 0.270 |
Why?
|
Consumer Product Safety | 1 | 2007 | 122 | 0.270 |
Why?
|
Tobacco Use Cessation | 1 | 2008 | 100 | 0.270 |
Why?
|
Genetic Engineering | 1 | 2011 | 936 | 0.260 |
Why?
|
Forecasting | 6 | 2022 | 2950 | 0.260 |
Why?
|
Health Services for the Aged | 1 | 2008 | 258 | 0.260 |
Why?
|
Biological Evolution | 1 | 2011 | 1081 | 0.260 |
Why?
|
Food Industry | 1 | 2006 | 68 | 0.250 |
Why?
|
Continuity of Patient Care | 2 | 2012 | 1076 | 0.250 |
Why?
|
Cost-Benefit Analysis | 14 | 2024 | 5532 | 0.250 |
Why?
|
Practice Guidelines as Topic | 5 | 2014 | 7451 | 0.250 |
Why?
|
Cost of Illness | 2 | 2013 | 1960 | 0.240 |
Why?
|
Drug Labeling | 1 | 2007 | 250 | 0.240 |
Why?
|
Confidentiality | 1 | 2008 | 606 | 0.230 |
Why?
|
Diet Therapy | 1 | 2005 | 151 | 0.230 |
Why?
|
Health Planning | 1 | 2005 | 233 | 0.230 |
Why?
|
Food Preferences | 1 | 2007 | 399 | 0.230 |
Why?
|
School Health Services | 1 | 2007 | 389 | 0.230 |
Why?
|
Seafood | 1 | 2007 | 395 | 0.220 |
Why?
|
Clinical Trials as Topic | 5 | 2008 | 8051 | 0.220 |
Why?
|
History, 20th Century | 4 | 2021 | 2772 | 0.220 |
Why?
|
Bioterrorism | 1 | 2004 | 144 | 0.220 |
Why?
|
Leadership | 1 | 2013 | 1395 | 0.220 |
Why?
|
Child Welfare | 1 | 2007 | 523 | 0.220 |
Why?
|
BCG Vaccine | 5 | 2001 | 383 | 0.210 |
Why?
|
Malaria | 1 | 2013 | 1240 | 0.210 |
Why?
|
National Health Programs | 1 | 2006 | 442 | 0.210 |
Why?
|
Nutrition Policy | 1 | 2007 | 467 | 0.210 |
Why?
|
International Cooperation | 5 | 2011 | 1439 | 0.210 |
Why?
|
Patient Participation | 2 | 2012 | 1450 | 0.210 |
Why?
|
History, 21st Century | 3 | 2021 | 1575 | 0.210 |
Why?
|
Health Education | 3 | 2013 | 1059 | 0.200 |
Why?
|
Health Status | 2 | 2013 | 4096 | 0.200 |
Why?
|
Needs Assessment | 1 | 2008 | 1146 | 0.200 |
Why?
|
Human Rights | 2 | 2017 | 312 | 0.200 |
Why?
|
Patient Care Team | 2 | 2012 | 2526 | 0.190 |
Why?
|
Disease Management | 1 | 2012 | 2533 | 0.190 |
Why?
|
Disclosure | 1 | 2007 | 750 | 0.190 |
Why?
|
Chronic Disease | 3 | 2013 | 9382 | 0.180 |
Why?
|
Influenza in Birds | 2 | 2015 | 76 | 0.180 |
Why?
|
Birds | 2 | 2015 | 167 | 0.180 |
Why?
|
Physicians | 4 | 2017 | 4615 | 0.180 |
Why?
|
Geriatric Assessment | 1 | 2008 | 1422 | 0.180 |
Why?
|
Disabled Persons | 2 | 2007 | 1218 | 0.180 |
Why?
|
Commerce | 1 | 2006 | 613 | 0.180 |
Why?
|
Technology Assessment, Biomedical | 4 | 1986 | 308 | 0.180 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2005 | 463 | 0.180 |
Why?
|
Wounds and Injuries | 1 | 2013 | 2518 | 0.180 |
Why?
|
Influenza A Virus, H5N1 Subtype | 2 | 2015 | 115 | 0.180 |
Why?
|
Hospital Bed Capacity | 1 | 2021 | 206 | 0.170 |
Why?
|
Protective Clothing | 1 | 2020 | 103 | 0.170 |
Why?
|
Models, Theoretical | 5 | 2001 | 3590 | 0.170 |
Why?
|
Health Expenditures | 2 | 2012 | 2391 | 0.170 |
Why?
|
Anniversaries and Special Events | 1 | 2020 | 97 | 0.170 |
Why?
|
Transplantation, Heterologous | 2 | 1998 | 2393 | 0.160 |
Why?
|
Mental Disorders | 1 | 2019 | 6879 | 0.160 |
Why?
|
Decision Making | 9 | 2016 | 3961 | 0.160 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2020 | 239 | 0.160 |
Why?
|
Risk Reduction Behavior | 1 | 2005 | 1120 | 0.160 |
Why?
|
Politics | 2 | 2017 | 821 | 0.150 |
Why?
|
Exercise Therapy | 1 | 2005 | 941 | 0.150 |
Why?
|
Diffusion of Innovation | 4 | 2014 | 730 | 0.150 |
Why?
|
Vaccination | 3 | 2022 | 3434 | 0.140 |
Why?
|
Risk Assessment | 7 | 2007 | 24311 | 0.140 |
Why?
|
Cost Savings | 2 | 2013 | 916 | 0.140 |
Why?
|
Exercise | 2 | 2024 | 5940 | 0.140 |
Why?
|
Perception | 1 | 2024 | 1207 | 0.140 |
Why?
|
Women's Health | 2 | 2005 | 2079 | 0.140 |
Why?
|
Neoplasms | 4 | 2012 | 22386 | 0.130 |
Why?
|
Interpersonal Relations | 2 | 2017 | 1439 | 0.130 |
Why?
|
Mass Screening | 5 | 2005 | 5455 | 0.130 |
Why?
|
Patient Education as Topic | 4 | 2013 | 2339 | 0.120 |
Why?
|
Survivors | 1 | 2006 | 2381 | 0.120 |
Why?
|
Diphtheria-Tetanus-Pertussis Vaccine | 2 | 1992 | 52 | 0.120 |
Why?
|
Physician-Patient Relations | 1 | 2008 | 3267 | 0.120 |
Why?
|
Foreign Professional Personnel | 1 | 2014 | 9 | 0.120 |
Why?
|
Mexico | 2 | 2007 | 766 | 0.120 |
Why?
|
Mammography | 1 | 2005 | 2436 | 0.110 |
Why?
|
Schools, Public Health | 1 | 1994 | 23 | 0.110 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2015 | 137 | 0.110 |
Why?
|
Bed Occupancy | 1 | 2013 | 38 | 0.110 |
Why?
|
Tuberculosis, Multidrug-Resistant | 2 | 1999 | 938 | 0.110 |
Why?
|
Urbanization | 1 | 2014 | 101 | 0.110 |
Why?
|
Economics | 1 | 2014 | 141 | 0.110 |
Why?
|
Encephalomyelitis, Acute Disseminated | 1 | 1993 | 68 | 0.110 |
Why?
|
World Health Organization | 2 | 2014 | 1328 | 0.100 |
Why?
|
Pneumococcal Infections | 1 | 2016 | 529 | 0.100 |
Why?
|
Reimbursement Mechanisms | 2 | 2010 | 677 | 0.100 |
Why?
|
Advisory Committees | 2 | 2011 | 797 | 0.100 |
Why?
|
Sodium Hypochlorite | 1 | 1991 | 31 | 0.100 |
Why?
|
Medical Assistance | 1 | 2012 | 108 | 0.090 |
Why?
|
Schools, Medical | 1 | 1998 | 881 | 0.090 |
Why?
|
Genetics | 1 | 2011 | 114 | 0.090 |
Why?
|
South Africa | 1 | 2017 | 1870 | 0.090 |
Why?
|
Smoking | 1 | 2008 | 9099 | 0.090 |
Why?
|
Interprofessional Relations | 1 | 2017 | 997 | 0.090 |
Why?
|
Health | 1 | 1994 | 399 | 0.090 |
Why?
|
Medical Informatics | 2 | 2021 | 737 | 0.090 |
Why?
|
Education, Professional | 1 | 2010 | 53 | 0.090 |
Why?
|
Financing, Government | 1 | 2013 | 473 | 0.090 |
Why?
|
Arthritis | 2 | 1992 | 685 | 0.090 |
Why?
|
Education, Nursing | 1 | 2010 | 83 | 0.080 |
Why?
|
Disinfection | 1 | 1991 | 207 | 0.080 |
Why?
|
Program Evaluation | 1 | 1998 | 2508 | 0.080 |
Why?
|
Tuberculosis, Pulmonary | 1 | 1996 | 846 | 0.080 |
Why?
|
Social Responsibility | 1 | 2012 | 385 | 0.080 |
Why?
|
HIV Seroprevalence | 1 | 1989 | 89 | 0.080 |
Why?
|
Physician Incentive Plans | 1 | 2010 | 164 | 0.080 |
Why?
|
AIDS Serodiagnosis | 1 | 1990 | 220 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 12 | 1983 | 20762 | 0.080 |
Why?
|
Holistic Health | 1 | 2008 | 48 | 0.080 |
Why?
|
Needles | 1 | 1991 | 455 | 0.080 |
Why?
|
Evaluation Studies as Topic | 8 | 1994 | 1629 | 0.080 |
Why?
|
Premarital Examinations | 1 | 1987 | 5 | 0.070 |
Why?
|
Opportunistic Infections | 1 | 1991 | 376 | 0.070 |
Why?
|
Health Behavior | 2 | 2013 | 2649 | 0.070 |
Why?
|
Employment, Supported | 1 | 2007 | 21 | 0.070 |
Why?
|
Probability | 7 | 1996 | 2483 | 0.070 |
Why?
|
Rehabilitation, Vocational | 1 | 2007 | 74 | 0.070 |
Why?
|
Brain Diseases | 2 | 1993 | 1553 | 0.070 |
Why?
|
Hospitals | 3 | 2013 | 3906 | 0.070 |
Why?
|
Safety | 3 | 2009 | 1159 | 0.070 |
Why?
|
Clinical Competence | 2 | 2021 | 4841 | 0.070 |
Why?
|
Japan | 1 | 2011 | 1418 | 0.070 |
Why?
|
Social Environment | 1 | 2012 | 1026 | 0.070 |
Why?
|
Substance Abuse, Intravenous | 1 | 1991 | 530 | 0.070 |
Why?
|
Clinical Pharmacy Information Systems | 1 | 2006 | 102 | 0.070 |
Why?
|
Social Security | 1 | 2007 | 101 | 0.070 |
Why?
|
Antitubercular Agents | 3 | 2001 | 1390 | 0.070 |
Why?
|
Curriculum | 2 | 2010 | 3778 | 0.070 |
Why?
|
Interdisciplinary Communication | 1 | 2012 | 937 | 0.070 |
Why?
|
Occupational Therapy | 1 | 2007 | 142 | 0.070 |
Why?
|
Child | 10 | 2013 | 80863 | 0.070 |
Why?
|
Risk | 8 | 2001 | 9642 | 0.060 |
Why?
|
Medication Systems, Hospital | 1 | 2006 | 154 | 0.060 |
Why?
|
Coronary Disease | 4 | 1987 | 5926 | 0.060 |
Why?
|
Pharmacy Service, Hospital | 1 | 2006 | 134 | 0.060 |
Why?
|
Antibodies, Viral | 2 | 1987 | 3212 | 0.060 |
Why?
|
Social Adjustment | 1 | 2007 | 636 | 0.060 |
Why?
|
Travel | 1 | 1991 | 800 | 0.060 |
Why?
|
HIV Infections | 6 | 1997 | 17564 | 0.060 |
Why?
|
Students, Medical | 2 | 1998 | 1962 | 0.060 |
Why?
|
Health Services | 1 | 1990 | 756 | 0.060 |
Why?
|
Costs and Cost Analysis | 6 | 1990 | 1670 | 0.060 |
Why?
|
Smallpox | 1 | 2004 | 43 | 0.060 |
Why?
|
Technology, Radiologic | 3 | 1983 | 160 | 0.060 |
Why?
|
Nutrition Assessment | 1 | 2007 | 740 | 0.060 |
Why?
|
Resource Allocation | 3 | 1994 | 353 | 0.060 |
Why?
|
Prospective Payment System | 1 | 1985 | 136 | 0.060 |
Why?
|
Coronary Care Units | 2 | 1984 | 235 | 0.050 |
Why?
|
Diagnosis-Related Groups | 1 | 1985 | 448 | 0.050 |
Why?
|
Medicare | 3 | 2013 | 6881 | 0.050 |
Why?
|
Transplantation | 1 | 1984 | 221 | 0.050 |
Why?
|
Nervous System Diseases | 1 | 1993 | 1668 | 0.050 |
Why?
|
Animals | 9 | 2015 | 169418 | 0.050 |
Why?
|
Organizational Policy | 1 | 2005 | 434 | 0.050 |
Why?
|
Polymyalgia Rheumatica | 1 | 1983 | 52 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 26351 | 0.050 |
Why?
|
Therapeutics | 2 | 1979 | 113 | 0.050 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2012 | 1189 | 0.050 |
Why?
|
Developed Countries | 2 | 2010 | 451 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2012 | 2239 | 0.050 |
Why?
|
Socioeconomic Factors | 2 | 2012 | 7863 | 0.050 |
Why?
|
Cimetidine | 1 | 1981 | 76 | 0.050 |
Why?
|
HIV | 3 | 2020 | 1596 | 0.050 |
Why?
|
Hospitalization | 2 | 2021 | 10845 | 0.050 |
Why?
|
Economics, Medical | 1 | 1982 | 112 | 0.050 |
Why?
|
Social Change | 2 | 2010 | 153 | 0.050 |
Why?
|
Guanidines | 1 | 1981 | 194 | 0.040 |
Why?
|
Disaster Planning | 1 | 2006 | 560 | 0.040 |
Why?
|
Disability Evaluation | 1 | 2007 | 1839 | 0.040 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8559 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3708 | 0.040 |
Why?
|
Peptic Ulcer | 1 | 1981 | 222 | 0.040 |
Why?
|
Leukocyte Count | 1 | 1984 | 1604 | 0.040 |
Why?
|
Quality Assurance, Health Care | 1 | 2010 | 2179 | 0.040 |
Why?
|
Anesthesia, Inhalation | 1 | 1980 | 221 | 0.040 |
Why?
|
Guidelines as Topic | 2 | 1998 | 1395 | 0.040 |
Why?
|
Immunization, Secondary | 1 | 2022 | 371 | 0.040 |
Why?
|
Developing Countries | 3 | 2010 | 2901 | 0.040 |
Why?
|
Voluntary Programs | 2 | 1990 | 48 | 0.040 |
Why?
|
Organizational Innovation | 2 | 2010 | 540 | 0.040 |
Why?
|
Drug Industry | 1 | 2005 | 793 | 0.040 |
Why?
|
Giant Cell Arteritis | 1 | 1983 | 307 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2014 | 3412 | 0.040 |
Why?
|
Animal Experimentation | 1 | 1998 | 46 | 0.040 |
Why?
|
Ethics | 1 | 1998 | 94 | 0.040 |
Why?
|
Academies and Institutes | 1 | 2020 | 326 | 0.040 |
Why?
|
Breast Neoplasms | 1 | 2005 | 21156 | 0.040 |
Why?
|
Anesthetics | 2 | 1980 | 525 | 0.040 |
Why?
|
Legislation, Medical | 1 | 1998 | 98 | 0.040 |
Why?
|
Social Control, Formal | 1 | 1998 | 107 | 0.040 |
Why?
|
Epidemiologic Methods | 3 | 1992 | 1337 | 0.030 |
Why?
|
Adolescent | 7 | 2007 | 89168 | 0.030 |
Why?
|
Blood Banks | 1 | 1997 | 108 | 0.030 |
Why?
|
Patient-Centered Care | 2 | 2021 | 1439 | 0.030 |
Why?
|
Statistics as Topic | 5 | 1985 | 2362 | 0.030 |
Why?
|
Diagnostic Errors | 2 | 2021 | 1282 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2004 | 1514 | 0.030 |
Why?
|
Female | 17 | 2013 | 396943 | 0.030 |
Why?
|
Bacterial Infections | 2 | 1984 | 1397 | 0.030 |
Why?
|
Medically Uninsured | 1 | 2001 | 841 | 0.030 |
Why?
|
Technology | 1 | 1978 | 296 | 0.030 |
Why?
|
Genomics | 1 | 2011 | 5909 | 0.030 |
Why?
|
Cost Control | 3 | 1985 | 627 | 0.030 |
Why?
|
Models, Biological | 2 | 2008 | 9505 | 0.030 |
Why?
|
Periodicals as Topic | 2 | 2004 | 1468 | 0.030 |
Why?
|
Patient Care Planning | 2 | 1979 | 904 | 0.030 |
Why?
|
Male | 18 | 2013 | 364781 | 0.030 |
Why?
|
Emergency Medicine | 1 | 2004 | 1222 | 0.030 |
Why?
|
Operating Rooms | 1 | 1980 | 799 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 1983 | 1891 | 0.030 |
Why?
|
New York City | 1 | 1996 | 738 | 0.030 |
Why?
|
Infant | 4 | 2000 | 36497 | 0.030 |
Why?
|
Torture | 1 | 1994 | 69 | 0.030 |
Why?
|
Time Factors | 3 | 2013 | 40271 | 0.030 |
Why?
|
Program Development | 1 | 1999 | 1296 | 0.030 |
Why?
|
Uncertainty | 1 | 1998 | 758 | 0.030 |
Why?
|
Canada | 1 | 1998 | 2143 | 0.030 |
Why?
|
HIV Seropositivity | 2 | 1997 | 963 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2000 | 26395 | 0.020 |
Why?
|
Acute Disease | 2 | 1993 | 7246 | 0.020 |
Why?
|
Arrhythmias, Cardiac | 1 | 1982 | 2258 | 0.020 |
Why?
|
Organizational Objectives | 1 | 1994 | 427 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2004 | 3063 | 0.020 |
Why?
|
Anesthesiology | 2 | 1980 | 1137 | 0.020 |
Why?
|
Angina Pectoris | 3 | 1984 | 960 | 0.020 |
Why?
|
Neutrophils | 1 | 1984 | 3790 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2005 | 4049 | 0.020 |
Why?
|
Age Distribution | 1 | 1996 | 2881 | 0.020 |
Why?
|
Professional Competence | 1 | 1994 | 431 | 0.020 |
Why?
|
Health Care Rationing | 1 | 1994 | 436 | 0.020 |
Why?
|
Models, Organizational | 1 | 1994 | 546 | 0.020 |
Why?
|
Prevalence | 3 | 2000 | 15880 | 0.020 |
Why?
|
HIV Antibodies | 2 | 1987 | 1341 | 0.020 |
Why?
|
Shock | 1 | 1992 | 316 | 0.020 |
Why?
|
International Agencies | 1 | 2010 | 245 | 0.020 |
Why?
|
Sociology | 1 | 1988 | 21 | 0.020 |
Why?
|
Contraceptive Devices, Male | 1 | 1988 | 13 | 0.020 |
Why?
|
Risk Factors | 4 | 2005 | 74915 | 0.020 |
Why?
|
Communication | 2 | 1983 | 3910 | 0.020 |
Why?
|
Swine | 1 | 1998 | 5996 | 0.020 |
Why?
|
Communicable Diseases | 1 | 1996 | 875 | 0.020 |
Why?
|
Legislation as Topic | 1 | 1987 | 76 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 1997 | 2010 | 0.020 |
Why?
|
Homosexuality | 1 | 1988 | 268 | 0.020 |
Why?
|
Computer Simulation | 1 | 2000 | 6278 | 0.020 |
Why?
|
Child, Preschool | 3 | 2000 | 42623 | 0.020 |
Why?
|
Case-Control Studies | 2 | 1995 | 22293 | 0.020 |
Why?
|
Adult | 11 | 2000 | 223542 | 0.020 |
Why?
|
Substance-Related Disorders | 2 | 1996 | 4453 | 0.020 |
Why?
|
Causality | 1 | 1992 | 1255 | 0.020 |
Why?
|
Radionuclide Imaging | 2 | 1982 | 1998 | 0.020 |
Why?
|
Survival Rate | 1 | 2000 | 12875 | 0.020 |
Why?
|
Health Resources | 2 | 1984 | 950 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 1997 | 3816 | 0.020 |
Why?
|
Social Justice | 1 | 1990 | 486 | 0.020 |
Why?
|
Awareness | 2 | 1987 | 654 | 0.020 |
Why?
|
Government Agencies | 1 | 1985 | 161 | 0.010 |
Why?
|
Coronary Thrombosis | 1 | 1987 | 440 | 0.010 |
Why?
|
Anaphylaxis | 1 | 1992 | 758 | 0.010 |
Why?
|
Prognosis | 1 | 2005 | 30028 | 0.010 |
Why?
|
Computers | 2 | 1984 | 592 | 0.010 |
Why?
|
Angioplasty, Balloon | 1 | 1987 | 592 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2001 | 5510 | 0.010 |
Why?
|
Hospital Units | 1 | 1984 | 142 | 0.010 |
Why?
|
Respiratory Tract Infections | 1 | 1991 | 1013 | 0.010 |
Why?
|
Home Care Services | 1 | 1990 | 655 | 0.010 |
Why?
|
Angina Pectoris, Variant | 1 | 1982 | 53 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2008 | 59680 | 0.010 |
Why?
|
Odds Ratio | 1 | 1995 | 9687 | 0.010 |
Why?
|
Massachusetts | 3 | 1983 | 8908 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 1991 | 1207 | 0.010 |
Why?
|
Cardiac Complexes, Premature | 1 | 1982 | 63 | 0.010 |
Why?
|
Random Allocation | 1 | 1987 | 2399 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 1980 | 5442 | 0.010 |
Why?
|
Poverty | 1 | 1994 | 2719 | 0.010 |
Why?
|
Therapeutic Equivalency | 1 | 1982 | 134 | 0.010 |
Why?
|
Duodenal Ulcer | 1 | 1981 | 121 | 0.010 |
Why?
|
Tetracycline | 1 | 1982 | 216 | 0.010 |
Why?
|
Stomach Ulcer | 1 | 1981 | 122 | 0.010 |
Why?
|
Cholecystectomy | 1 | 1983 | 409 | 0.010 |
Why?
|
False Negative Reactions | 2 | 1997 | 575 | 0.010 |
Why?
|
Explosions | 1 | 1980 | 107 | 0.010 |
Why?
|
Ethics, Medical | 1 | 1985 | 785 | 0.010 |
Why?
|
Bacterial Vaccines | 1 | 1982 | 400 | 0.010 |
Why?
|
Aged | 4 | 2008 | 171520 | 0.010 |
Why?
|
Drug and Narcotic Control | 1 | 1980 | 146 | 0.010 |
Why?
|
Thorax | 1 | 1982 | 559 | 0.010 |
Why?
|
Middle Aged | 8 | 1996 | 223418 | 0.010 |
Why?
|
Electrocardiography | 2 | 1982 | 6410 | 0.010 |
Why?
|
Hospitals, Teaching | 1 | 1983 | 1158 | 0.010 |
Why?
|
Blindness | 1 | 1983 | 588 | 0.010 |
Why?
|
Abortion, Therapeutic | 1 | 1978 | 35 | 0.010 |
Why?
|
Sexual Behavior | 1 | 1988 | 2200 | 0.010 |
Why?
|
Halothane | 1 | 1978 | 200 | 0.010 |
Why?
|
Prospective Studies | 4 | 1992 | 54914 | 0.010 |
Why?
|
Double-Blind Method | 1 | 1992 | 12450 | 0.010 |
Why?
|
Pneumoencephalography | 1 | 1977 | 22 | 0.010 |
Why?
|
Nitrous Oxide | 1 | 1978 | 166 | 0.010 |
Why?
|
Insurance, Health | 1 | 1990 | 2513 | 0.010 |
Why?
|
Angiography | 1 | 1982 | 1598 | 0.010 |
Why?
|
Education, Medical, Continuing | 2 | 1983 | 829 | 0.010 |
Why?
|
Coronary Artery Bypass | 2 | 1984 | 2194 | 0.010 |
Why?
|
Reference Values | 1 | 1984 | 4941 | 0.010 |
Why?
|
Clinical Laboratory Techniques | 1 | 1982 | 749 | 0.010 |
Why?
|
Medicaid | 1 | 1990 | 2843 | 0.010 |
Why?
|
Population Surveillance | 1 | 1986 | 2601 | 0.010 |
Why?
|
Streptococcus pneumoniae | 1 | 1982 | 765 | 0.010 |
Why?
|
Coronary Vessels | 1 | 1987 | 3122 | 0.010 |
Why?
|
Data Collection | 1 | 1985 | 3329 | 0.010 |
Why?
|
Blood Donors | 1 | 1997 | 345 | 0.010 |
Why?
|
Drug Storage | 1 | 1995 | 52 | 0.010 |
Why?
|
Posture | 1 | 1979 | 956 | 0.010 |
Why?
|
Coronary Angiography | 2 | 1987 | 4526 | 0.010 |
Why?
|
Longevity | 1 | 1982 | 1077 | 0.010 |
Why?
|
Exercise Test | 1 | 1982 | 2186 | 0.010 |
Why?
|
Myocardial Infarction | 3 | 1987 | 11515 | 0.010 |
Why?
|
Mycobacterium Infections | 1 | 1995 | 122 | 0.010 |
Why?
|
Tuberculin Test | 1 | 1995 | 205 | 0.010 |
Why?
|
Climate | 1 | 1995 | 148 | 0.010 |
Why?
|
Liver Diseases | 2 | 1980 | 1307 | 0.010 |
Why?
|
MEDLINE | 1 | 1994 | 119 | 0.010 |
Why?
|
Feces | 1 | 1980 | 1515 | 0.010 |
Why?
|
Urinary Tract Infections | 1 | 1980 | 806 | 0.010 |
Why?
|
Sunlight | 1 | 1995 | 337 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 1983 | 1816 | 0.010 |
Why?
|
Ambulatory Care | 1 | 1984 | 2780 | 0.010 |
Why?
|
Geography | 1 | 1995 | 654 | 0.010 |
Why?
|
Radiotherapy | 1 | 1979 | 1510 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 1979 | 2925 | 0.010 |
Why?
|
Hodgkin Disease | 1 | 1980 | 1386 | 0.010 |
Why?
|
Community Health Services | 1 | 1977 | 659 | 0.010 |
Why?
|
Health Services Needs and Demand | 1 | 1979 | 1408 | 0.010 |
Why?
|
Retrospective Studies | 4 | 1992 | 81834 | 0.010 |
Why?
|
Cerebral Angiography | 1 | 1977 | 1282 | 0.010 |
Why?
|
Burns | 1 | 1983 | 1887 | 0.010 |
Why?
|
Virulence | 1 | 1995 | 1303 | 0.010 |
Why?
|
Biopsy | 1 | 1983 | 6816 | 0.010 |
Why?
|
Cerebrovascular Disorders | 1 | 1977 | 1487 | 0.010 |
Why?
|
Education, Medical, Undergraduate | 1 | 1979 | 1081 | 0.010 |
Why?
|
Heart Ventricles | 1 | 1982 | 3839 | 0.010 |
Why?
|
Bacteria | 1 | 1980 | 2226 | 0.010 |
Why?
|
Heart | 1 | 1982 | 4451 | 0.010 |
Why?
|
Length of Stay | 1 | 1983 | 6521 | 0.010 |
Why?
|
Treatment Outcome | 1 | 1995 | 65409 | 0.000 |
Why?
|
Pain | 1 | 1982 | 5096 | 0.000 |
Why?
|
Pregnancy | 2 | 1979 | 30179 | 0.000 |
Why?
|
Drug Evaluation | 1 | 1987 | 642 | 0.000 |
Why?
|
Ultrasonography | 1 | 1979 | 5995 | 0.000 |
Why?
|
Hemorrhage | 1 | 1978 | 3458 | 0.000 |
Why?
|
Decision Trees | 1 | 1987 | 510 | 0.000 |
Why?
|
Regression Analysis | 1 | 1995 | 6353 | 0.000 |
Why?
|
Age Factors | 1 | 1982 | 18478 | 0.000 |
Why?
|
Neoplasm Staging | 1 | 1979 | 11249 | 0.000 |
Why?
|
Insurance, Hospitalization | 1 | 1983 | 30 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 1982 | 7471 | 0.000 |
Why?
|
Hospital Bed Capacity, 500 and over | 1 | 1982 | 113 | 0.000 |
Why?
|
Emergency Service, Hospital | 1 | 1982 | 7956 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 1997 | 14728 | 0.000 |
Why?
|
Methods | 1 | 1982 | 1067 | 0.000 |
Why?
|
Fees and Charges | 1 | 1983 | 192 | 0.000 |
Why?
|
Connecticut | 1 | 1982 | 365 | 0.000 |
Why?
|
Vitamin D | 1 | 1995 | 3311 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1979 | 9425 | 0.000 |
Why?
|
Dental Caries | 1 | 1985 | 429 | 0.000 |
Why?
|
New England | 1 | 1983 | 1056 | 0.000 |
Why?
|
Behavior Therapy | 1 | 1985 | 885 | 0.000 |
Why?
|
Hospitals, University | 1 | 1980 | 569 | 0.000 |
Why?
|
Mental Processes | 1 | 1979 | 247 | 0.000 |
Why?
|
Research Design | 1 | 1994 | 6217 | 0.000 |
Why?
|
Jaundice | 1 | 1978 | 95 | 0.000 |
Why?
|
Mediastinal Diseases | 1 | 1978 | 91 | 0.000 |
Why?
|
Diagnostic Tests, Routine | 1 | 1982 | 792 | 0.000 |
Why?
|
Pancreatic Diseases | 1 | 1978 | 353 | 0.000 |
Why?
|
Attitude to Health | 1 | 1985 | 2030 | 0.000 |
Why?
|
Brain Neoplasms | 1 | 1977 | 9182 | 0.000 |
Why?
|
Triage | 1 | 1982 | 997 | 0.000 |
Why?
|
Recurrence | 1 | 1987 | 8510 | 0.000 |
Why?
|
Bone Diseases | 1 | 1978 | 418 | 0.000 |
Why?
|
Educational Measurement | 1 | 1981 | 1256 | 0.000 |
Why?
|
Stroke Volume | 1 | 1987 | 5620 | 0.000 |
Why?
|
Faculty, Medical | 1 | 1981 | 1218 | 0.000 |
Why?
|
Life Style | 1 | 1985 | 3929 | 0.000 |
Why?
|
Teaching | 1 | 1979 | 1174 | 0.000 |
Why?
|
Lymphoma | 1 | 1978 | 1907 | 0.000 |
Why?
|
Kidney Diseases | 1 | 1978 | 2102 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1982 | 13026 | 0.000 |
Why?
|
Attitude of Health Personnel | 1 | 1980 | 3922 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 1982 | 39430 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 1978 | 13589 | 0.000 |
Why?
|